Skip to main content

Journal of Cancer Survivorship

Ausgabe 6/2023

Inhalt (25 Artikel)

Open Access Original Research

Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial

Anna C. Singleton, Rebecca Raeside, Stephanie R. Partridge, Karice K. Hyun, Justin Tat-Ko, Stephanie Che Mun Sum, Molly Hayes, Clara K. Chow, Aravinda Thiagalingam, Katherine Maka, Kerry A. Sherman, Elisabeth Elder, Julie Redfern

Healthcare providers’ promotion of physical activity among child and adolescent cancer survivors: strategies and challenges

Julia Shabanian, Jessica M. Capaldi, Bianca Luna-Lupercio, Laurel J. Finster, Kara Noskoff, Hilary Gan, Simon Davies, Susan L. Whiteway, Celina H. Shirazipour

Cancer pain and alcohol self-medication

Collin M. Calvert, Diana Burgess, Darin Erickson, Rachel Widome, Rhonda Jones-Webb

Financial burdens during the COVID-19 pandemic are related to disrupted healthcare utilization among survivors of adolescent and young adult cancers

Judy Y. Ou, Austin R. Waters, Heydon K. Kaddas, Echo L. Warner, Perla L. Vaca Lopez, Karely Mann, John S. Anderson, Nicole Ray, Tomoko Tsukamoto, David Gill, Lauri Linder, Douglas Fair, Anne C. Kirchhoff

Open Access

A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment

Janette L. Vardy, Gregory R. Pond, Melanie L. Bell, Corrinne Renton, Ann Dixon, Haryana M. Dhillon

Review

Racial disparities in treatment-related cardiovascular toxicities amongst women with breast cancer: a scoping review

Arnethea L. Sutton, Ashley S. Felix, Stacey Wahl, R. Lee Franco, Zachary Leicht, Karen Patricia Williams, W. Gregory Hundley, Vanessa B. Sheppard

Open Access

The effect of changing pregnancy intentions on preconception health behaviors: a prospective cohort study

Hena Naz Din, David Strong, Savitri Singh-Carlson, Heather L. Corliss, Sheri J. Hartman, Hala Madanat, H. Irene Su

Open Access Review

Quantification of breast lymphoedema following conservative breast cancer treatment: a systematic review

Nicola Fearn, Catalina Llanos, Elizabeth Dylke, Kirsty Stuart, Sharon Kilbreath

Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008–2017

Andrea C. Betts, Caitlin C. Murphy, L. Aubree Shay, Bijal A. Balasubramanian, Christine Markham, Michael E. Roth, Marlyn Allicock

Treating persistent pain after breast cancer: practice gaps and future directions

An De Groef, Mira Meeus, Lauren C. Heathcote, Louise Wiles, Mark Catley, Anna Vogelzang, Ian Olver, William B. Runciman, Peter Hibbert, Lore Dams, Bart Morlion, G. Lorimer Moseley

Utilization of cancer survivorship services during the COVID-19 pandemic in a tertiary referral center

Bridget A. Oppong, Maryam B. Lustberg, Timiya S. Nolan, Theresa Relation, Ko Un Park, Erin Healy, Annie Trance, Dori L. Klemanski

Return to work in head and neck cancer survivors: its relationship with functional, psychological, and disease-treatment factors

Pi-Ling Tsai, Chen-Ping Wang, Yuan-Yuan Fang, Yen-Ju Chen, Shu-Ching Chen, Min-Ru Chen, Jenq-Yuh Ko, Jiu-Jenq Lin, Pei-Jen Lou, Yeur-Hur Lai

Review

The influence of telehealth-based cancer rehabilitation interventions on disability: a systematic review

Rachelle Brick, Lynne Padgett, Jennifer Jones, Kelley Covington Wood, Mackenzi Pergolotti, Timothy F. Marshall, Grace Campbell, Rachel Eilers, Sareh Keshavarzi, Ann Marie Flores, Julie K. Silver, Aneesha Virani, Alicia A. Livinski, Mohammed Faizan Ahmed, Tiffany Kendig, Bismah Khalid, Jeremy Barnett, Anita Borhani, Graysen Bernard, Kathleen Doyle Lyons

Adherence to healthy lifestyle recommendations in Brazilian cancer survivors

Bruna de Lima Melo, Dayara Cristina Amaro Vieira, Gabriela Coelho de Oliveira, Juliana Valente, Zila Sanchez, Gerson Ferrari, Lidiane Pereira Magalhães, Leandro F. M. Rezende

Long-term changes of cognitive impairment among older breast cancer survivors

Juhua Luo, John T. Schousboe, Kristine E. Ensrud, Michael Hendryx

Open Access

Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma

Jinman Zhuang, Yuhang Liu, Xinying Xu, Yuxin Cai, Maolin Liu, Zishan Chen, Shuyan Yang, Jianbo Lin, Zhijian Hu, Mingqiang Kang, Mengxin Lin, Fei He

Open Access Review

What is the evidence behind cancer care reviews, a primary care cancer support tool? A scoping review

Dipesh P. Gopal, Tahania Ahmad, Nikolaos Efstathiou, Ping Guo, Stephanie J. C. Taylor

The long-term financial experiences of adolescent and young adult cancer survivors

Bridgette Thom, Danielle N. Friedman, Emeline M. Aviki, Catherine Benedict, Samantha E. Watson, Michelle S. Zeitler, Fumiko Chino

Association of financial worry with substance use, mental health, and quality of life in cancer patients

Salene M. W. Jones, Mimi Ton, Jaimee L. Heffner, Rachel C. Malen, Stacey A. Cohen, Polly A. Newcomb

Review

Physical activity intervention benefits persist months post-intervention: randomized trial in breast cancer survivors

Laura Q. Rogers, Kerry S. Courneya, Robert A. Oster, Philip M. Anton, Siobhan Phillips, Diane K. Ehlers, Edward McAuley

Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland

Karin Ribi, Eleonora Pagan, Isabella Sala, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Agnes Glaus, Rossana Berardi, Alessandra Franzetti-Pellanda, Vincenzo Bagnardi, Shari Gelber, Ann H. Partridge, Aron Goldhirsch, Olivia Pagani

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.